SCHEMBL9032073

SCHEMBL9032073

CCCCc1nn(-c2c(Cl)cccc2C(=O)OC)c(=O)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9032835 0.92 AGTR1 (0.55) —
SCHEMBL9032388 0.90 AGTR1 (0.59) —
SCHEMBL9033418 0.90 — —
SCHEMBL9031785 0.85 AGTR1 (0.54) —
SCHEMBL9032091 0.85 AGTR1 (0.60) —
SCHEMBL9031930 0.84 — —
SCHEMBL9034260 0.83 AGTR1 (0.59) —
SCHEMBL9032636 0.82 AGTR1 (0.57) —
SCHEMBL9033249 0.82 AGTR1 (0.52) —
SCHEMBL9031734 0.81 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0412594-B1 Substituted triazolinones, triazolinethiones, and triazolinimines as angiotensin II antagonists MERCK & CO INC (US) 1996-01-03 — — EP disclosed
EP-0412594-A2 Substituted triazolinones, triazolinethiones, and triazolinimines as angiotensin II antagonists MERCK & CO. INC. (US) 1991-02-13 — — EP disclosed
Send feedback